Tango Therapeutics Inc. (TNGX)
NASDAQ · Healthcare
Tango Therapeutics Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Tango Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 346.2M, a 73.51% increase year-over-year.
- Tango Therapeutics Inc. shareholder equity for 2025 were 346.2M, a 73.51% increase from 2024.
- Tango Therapeutics Inc. shareholder equity for 2024 were 199.5M, a 21.17% decrease from 2023.
- Tango Therapeutics Inc. shareholder equity for 2023 were 253.1M, a 1.46% increase from 2022.
- Tango Therapeutics Inc. shareholder equity for 2022 were 249.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Tango Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $346 |
| 2024 | $200 |
| 2023 | $253 |
| 2022 | $249 |
| 2021 | $345 |
| 2020 | $39 |
| Tango Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $346 |
| 2024-12-31 | $200 |
| 2023-12-31 | $253 |
| 2022-12-31 | $249 |
| 2021-12-31 | $345 |
| 2020-12-31 | $39 |
Tango Therapeutics Inc. Shareholder Equity — FAQ
Tango Therapeutics Inc. (TNGX) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TNGX's shareholder equity history?
The chart and table above show Tango Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.